Avalyn Pharma, Inc. (AVLN)
26.04
-1.21
(-4.44%)
USD |
NASDAQ |
Oct 23, 16:00
26.04
0.00 (0.00%)
After-Hours: 19:12
Avalyn Pharma Market Cap : 1.154B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 22, 2026 | 1.208B |
| October 21, 2026 | 1.113B |
| October 20, 2026 | 1.092B |
| October 19, 2026 | 1.034B |
| October 16, 2026 | 1.049B |
| October 15, 2026 | 1.092B |
| October 14, 2026 | 1.050B |
| October 13, 2026 | 1.052B |
| October 12, 2026 | 1.099B |
| October 09, 2026 | 1.142B |
| October 08, 2026 | 1.140B |
| October 07, 2026 | 1.132B |
| October 06, 2026 | 1.127B |
| October 05, 2026 | 1.198B |
| October 02, 2026 | 1.247B |
| October 01, 2026 | 1.216B |
| September 30, 2026 | 1.263B |
| September 29, 2026 | 1.201B |
| September 28, 2026 | 1.256B |
| September 25, 2026 | 1.245B |
| September 24, 2026 | 1.266B |
| September 23, 2026 | 1.315B |
| September 22, 2026 | 1.439B |
| September 21, 2026 | 1.402B |
| September 18, 2026 | 1.397B |
| Date | Value |
|---|---|
| September 17, 2026 | 1.482B |
| September 16, 2026 | 1.539B |
| September 15, 2026 | 1.520B |
| September 14, 2026 | 1.551B |
| September 11, 2026 | 1.488B |
| September 10, 2026 | 1.537B |
| September 09, 2026 | 1.591B |
| September 08, 2026 | 1.668B |
| September 04, 2026 | 1.658B |
| September 03, 2026 | 1.571B |
| September 02, 2026 | 1.577B |
| September 01, 2026 | 1.564B |
| August 31, 2026 | 1.540B |
| August 28, 2026 | 1.538B |
| August 27, 2026 | 1.619B |
| August 26, 2026 | 1.642B |
| August 25, 2026 | 1.694B |
| August 24, 2026 | 1.671B |
| August 21, 2026 | 1.701B |
| August 20, 2026 | 1.646B |
| August 19, 2026 | 1.728B |
| August 18, 2026 | 1.723B |
| August 17, 2026 | 1.696B |
| August 14, 2026 | 1.740B |
| August 13, 2026 | 1.622B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Filana Therapeutics, Inc. | 31.31M |
| CorMedix, Inc. | 610.46M |
| Eloxx Pharmaceuticals, Inc. | 51.83M |
| Breakthrough Chemistry, Inc. | 0.9729M |
| BioStem Technologies, Inc. | 28.16M |
Market Cap Related Metrics
| Price to Book Value | 2.898 |
| Price | 26.04 |
| Earnings Yield | -8.10% |